Hims & Hers Health Net Long-Term Debt 2020-2025 | HIMS

Hims & Hers Health annual/quarterly net long-term debt history and growth rate from 2020 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
  • Hims & Hers Health net long-term debt for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Hims & Hers Health net long-term debt for the twelve months ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Hims & Hers Health annual net long-term debt for 2024 was $0B, a 0% decline from 2023.
  • Hims & Hers Health annual net long-term debt for 2023 was $0B, a 0% decline from 2022.
  • Hims & Hers Health annual net long-term debt for 2022 was $0B, a 0% decline from 2021.
Hims & Hers Health Annual Net Long-Term Debt
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $-2
2019 $-7
2018 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $11.277B $1.477B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.130B 58.69
Doximity (DOCS) United States $11.290B 52.27
Tempus AI (TEM) United States $10.557B 0.00
IRhythm Technologies (IRTC) United States $4.350B 0.00
Inspire Medical Systems (INSP) United States $3.741B 58.45
Hinge Health (HNGE) United States $3.664B 0.00
Privia Health (PRVA) United States $2.391B 163.42
Schrodinger (SDGR) United States $1.574B 0.00
Phreesia (PHR) United States $1.516B 0.00
Enovis (ENOV) United States $1.502B 8.37
Clover Health Investments (CLOV) United States $1.496B 0.00
10x Genomics (TXG) United States $1.496B 0.00
Azenta (AZTA) United States $1.427B 66.30
Omnicell (OMCL) United States $1.259B 22.22
Evolent Health (EVH) United States $1.119B 95.30
Claritev (CTEV) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.541B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.467B 0.00
Butterfly Network (BFLY) United States $0.462B 0.00
Talkspace (TALK) United States $0.415B 124.00
TruBridge (TBRG) United States $0.336B 746.33
Outset Medical (OM) United States $0.309B 0.00
Nyxoah SA (NYXH) Belgium $0.280B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
CapsoVision (CV) United States $0.211B 0.00
Zepp Health (ZEPP) Netherlands $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.155B 0.00
Pulmonx (LUNG) United States $0.127B 0.00
American Well (AMWL) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.114B 0.00
CareCloud (CCLD) United States $0.101B 3.85
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.079B 0.00
111 (YI) China $0.066B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00